Treatment for Ménières disease

Today we have several effective treatments for Ménières disease (MD). The symptoms in Ménière disease can vary a lot over time, but in most cases, we find a treatment option that works and the dizziness goes away.

The variation in the disease has made it very difficult to assess the effectiveness of the different treatments in medical trials. Because of this, you as a patient, might experience that different doctors will give you slightly different advice on treatments options.

I will try to give an overview of the different treatment options here.

Non-pharmaceutical options:

Patients with MD are more vulnerable to dietary and environmental factors, and triggers may include high salt intake, caffeine, alcohol, nicotine, stress and allergies (food and environmental). Among patients with identified triggers, avoidance or minimization of exposure to these substances, as well as treatment for allergies if appropriate, may alleviate or ameliorate symptoms.

Salt restriction is often recommended although there is a lack of data supporting the efficacy of this approach. The US-based database UptoDate recommends a maximum intake of 2 to 3 g of sodium daily in Ménière patients, with the daily sodium intake evenly spread across meals to avoid a large bolus at any time. Our clinic simply recommends to avoid excess intake of salt since studies lack support of cutting out salt, and also because of too low sodium blood levels also can give dizziness symptoms.

Vestibular rehabilitation is a form of rehabilitation that is more commonly used in other vestibular conditions, but can also be helpful in individuals with MD. It seems to especially helpful in the end-phase of MD and also if the individual experience sensitivity to sudden changes in the field of vision (like looking at tree branches moving or striped walls),


Pharmaceutical options:

Medications to take during an attack

Regular motion sickness tablets like Postafen can be used in attacks, but the most effective one seems to be Stemetil (proklorperazin).
Stemetil is effective for reducing dizziness in a Ménière attack and is harmless if used sporadically. If too much Stemetil is used over time it can give reversible side effects that mimics Parkinsons disease (extrapyramidal side effects).

Prophylactic medication that you take every day

Diuretics

For many years diuretics have been used to treat Ménières disease. Multiple low evidence–level studies report that oral diuretic therapy may be beneficial in the medical management of Ménière’s disease. Improvement in vertigo episode frequency was consistently reported, with less convincing evidence for improvement in hearing outcomes.

In Norway, all MD patients are supposed to initially try diuretics treatment. Only if this is ineffective, other medications can be prescribed on “blue prescription”, that is subsidized by the government. This is the reason we always try with diuretics first. Diuretics are cheap with very little side effects. There is a small risk of developing kidney stones, and the blood potassium (k+) levels can also become lower if used over time. Because of this we recommend that the patient take a break, and stop using them every 3-6 months and see what happens. If you use them over a longer time, ask your GP (fastlege) to check your Na/K levels a couple of times a year.

Betaserc (betahistin)

Nobody knows for sure how betahistin works. Pharmacologically it is a strong H3(histamin) receptor antagonist and weak H1 (histamin) receptor agonist. Several studies have been performed and these studies have not proven any effect.

Even so,  several doctors and patients have anecdotal experience of  very good betahistin effect on several of the dizziness symptoms that comes with Meniers disease. Since this effect has not been proven in studies you might experience that some doctors are positive towards betahistin and others are more sceptical against using it.

It is a harmless medication, but side effects like stomach pain and minor allergic reactions may occur.

Our clinic recommend that you try betahistin after diuretics have been tried. We usually increase the dosage until we see effect, or until side effects occur, in which case the dosage is reduced to a tolerable level.

SPC (Specially processed cereals)-flakes

SPC flakes is a specially processed oat meal that makes the body produce antisecretoric factor (af). Af is a protein in the inner ear.

This treatment is complety harmless unless you have gluten intolerance.
In some cases this treatment can reduce the dizziness attacks.

Invasive (surgical) treatments

Intratympanic injection of corticosteroid (cortison)

By injecting cortison directly into the middle ear, the cortison concentration in the inner ear can get very high without getting cortison side effects in the entire body.

Several studies have shown that this treatment might be very efficient in reducing the dizziness attacks.

Studies have not proved that this treatment can improve hearing, but some patients have experienced hearing improvement if the treatment is given early in the Ménières disease, before the hearing loss has become permanent.
There is a 5% risk that the small hole created in the eardrum does not heal afterwards.

Grommet (dren)

Biochemical processes in the cells in the ear creates a negative pressure in the middle ear.  This pressure is regulated when you swallow. When we install a grommet in the ear this vacuum effect is equalized and the middle ear pressure is kept constant.

For some individuals with Ménière this helps against dizziness attacks and especially on the pressure sensation in the ear. If the pressure sensation is the most prominent symptom, we often recommend grommet as one of the first treatments.

Intratympanic injection of Gentamycin

Gentamycin is an antibiotic that damages the receptor cells in the inner ear. By injecting this we create a damage to the balance system. In 90% of the cases, it  makes the dizziness attacks go away.

The damage to the balance system creates a new form of unsteadiness and the patients need vestibular rehabilitation afterwards. In most cases this makes the unsteadiness go away. Elderly patients, however, may experience unsteadiness several years after Gentamycin treatment.

There is also a 30% risk of damaging the hearing further with this treatment.

Some individuals develop Ménière disease in both ears. Gentamycin treatment might weaken the balance function some. This is usually not a problem if you have normal balance function on the other side. However, if at a later stage, MD is also developed on the other side, theoretically one might expect more problems with  balance if one or both ears are Gentamycin-treated. The long-term balance function after Gentamycin injections on the first ear has not been evaluated fully.

Because of these side effects we always try cortison injections and/or grommet before considering Gentamycin injections or surgery.

Pressure-giving devices

MeniQ and Meniett are two devices that have been used. Some patients seem to have had effect with these. In order to use Meniett you need to have a grommet installed first. At the moment these devices are difficult to obtain in Norway.

Surgery

There are several types of surgery performed in Ménières disease. Complete destruction of the balance system can be done by cutting the balance nerve (neurectomy) or by drilling out the inner ear (labyrinthectomy). These surgeries are very rarely done, since Gentamycin injections can achieve almost the same effect with lower risk.

Another surgery is saccotomi where bone is removed around the endolymphatic sac. This is believed to improve pressure regulation in the inner ear. This operation has lower risk than the other two mentioned above and is occasionally performed in Norway.

If the hearing is impaired on both ears and speech perception is difficult, cochlear implant surgery may be an option. Ménières disease is one of the conditions where a cochlear implant usually have a good result. Cochlear implant is only an option if the hearing is very bad and hearing aids have been tried and does not give sufficient hearing. Talk to your ENT doctor about referral to a cochlear implant center if you think you might be a candidate for a cochlear implant.

Sources:

www.uptodate.com
The book «Det snurrar» av Geisler and Karlberg
Several papers (more citations will soon be added)

D-Vitamin and BPPV

By:Karl Nordfalk

BPPV is caused by calcium-carbonate crystals that dislodges from the utricle and move into the semi-circular canals. The crystals contain calcium and D-Vitamin is important for regulating calcium. Because of this several studies have examined the relation between D-Vitamin levels and BPPV.

Vitamin levels are measured in 25(OH)D
(=sum of 25(OH)D2 + 25(OH)D3) and can be reported in ng/ml or nmol/l. All values are converted to nmol/l in this report since this is the current standard in the Nordic countries. For conversion: ng/ml x 2.5 = nmol/l.

Jeong et al. reported that patients with BPPV have significantly lower D-Vitamin levels (36 nmol/l) than a general population (47.5 nmol/l). Since this is cross-sectional study it is not possible to say if low D-Vitamin is the cause or effect of BPPV in the study group.

Talaat et al. examined individuals who both had BPPV and low D-Vitamin levels (<25 nmol/l). They gave D-Vitamin supplement and found that individuals who responded well to treatment and increased their 25(OH)D level by more than 25 nmol/l had fewer BPPV attacks.

Should we administer supplementary D-Vitamin to BPPV patients?
– The evidence level that D-Vitamin helps reduce BPPV attacks is quite low (IIb/3) but small studies indicate that increasing D-Vitamin might decrease the risk for recurrent BPPV. If a patient suffers from recurrent BPPV it is possible, but not proved, that increasing the D-Vitamin levels might help reduce attacks.

What serum level 25(OH)D should we aim for in BPPV patients?
– The optimal D-Vitamin level is, as of June 2017, still controversial. A 2017 review concluded that the most advantageous serum levels for 25(OH)D for all outcomes appeared to be close to 75 nmol/l. This level is also recommended by D-Vitamin producers. A Nordic consensus group from 2017 recommended 50 nmol/l as goal level.

Jeong SH, Kim JS, Shin JW, Kim S, Lee H, Lee AY, Kim JM, Jo H, Song J, Ghim
Decreased serum vitamin D in idiopathic benign paroxysmal positional vertigo.
J Neurol. 2013 Mar;260(3):832-8. Pubmed link

Talaat HS, Kabel AM, Khaliel LH, Abuhadied G, El-Naga HA, Talaat AS.
Reduction of recurrence rate of benign paroxysmal positional vertigo by treatment of severe vitamin D deficiency.
Auris Nasus Larynx. 2016 Jun;43(3):237-41. Pubmed link

Bischoff-Ferrari
Optimal serum 25-hydroxyvitamin D levels for multiple health outcomes. Advances in Experimental Medicine and Biology (Review). 2014. 810: 500–25.
Pubmed link

Brustad M, Meyer HE.
Vitamin D–how much is enough, and is more better for your Health?

Tidsskr Nor Laegeforen. 2014 Apr 8;134(7):726-8. doi:10.4045/tidsskr.13.1513.
Tidsskriftet link

Treatment in TRV-Chair

By: Karl Nordfalk

The TRV Chair was designed by Thomas Richard-Vitton for diagnosis and treatment of Benign Paroxysmal Positional Vertigo (BPPV). BPPV can in many cases be treated with traditional maneuvers on bench such as the Epley, Semont, BBQ, Gufoni and Appiani.

With the TRV chair the sensitivity of the diagnostics and effectiveness of the maneuvers can be enhanced by following the exact plane of the canal and by adding kinetic energy to the maneuvers. With the TRV chair it is also  possible to treat patients with neck and back problems.

West et al. described 150 subjects who were treated with the TRV chair or another bi-axial rotational device, the Epley Omiax, at Rikshospitalet in Copenhagen. 91.7–100 % of the subjects experienced reduction of symptoms after 1-3 treatments. Horizontal cupulolithiasis and multi-canal affection constituted the most difficult cases to treat and cure.

Tan et al. performed a non-randomized prospective study of 165 subjects with posterior canal BPPV and found that 85.2% of the subjects were cured after one week the TRV-chair group compared to 72.6% in the group who received standard treatment. The difference was statistically significant.

West N, Hansen S, Møller MN, Bloch SL, Klokker M. Repositioning chairs in benign paroxysmal positional vertigo: implications and clinical outcome.
Eur Arch Otorhinolaryngol. 2016 Mar;273(3):573-80
Pubmed link

Tan J, Yu D, Feng Y, Song Q, You J, Shi H, Yin S.
Comparative study of the efficacy of the canalith repositioning procedure versus the vertigo treatment and rehabilitation chair.
Acta Otolaryngol. 2014 Jul;134(7):704-8
Pubmed link

Richard-Vitton T, Viirre E.
Unsteadiness and drunkenness sensations as a new sub-type of BPPV.
Rev Laryngol Otol Rhinol (Bord). 2011;132(2):75-80.
Pubmed link

 

Home treatment for BPPV

Click here for Norwegian text

Before you start with these exercises it is important that you have been diagnosed by a spesialist on BPPV.

Treatment for BPPV in the right posterior semicircular canal. -> Can be performed 1-2 times morning and evening
– Semont maneuver right

Treatment for BPPV in the left posterior semicircular canal. -> Can be performed 1-2 times morning and evening
– Semont maneuver left

Treatment for BPPV in the right horizontal semicircular canal -> Can be performed 1-2 times morning or/and evening.
-BBQ maneuver right

Treatment for BPPV in the left horizontal semicircular canal -> Can be performed 1-2 times morning or/and evening.
-BBQ maneuver left

Treatment for BPPV in the anterior semicircular canals. -> Perform once/day. Stop if you experience pain in the neck region.
– Deep Head Hanging Maneuver